Mani revises financials, eyes strategic expansion and stronger 2026 outlook

Mani Inc. announced a partial correction to its consolidated financial results for the fiscal year ended August 31, 2025, originally disclosed on October 8, 2025. The company revised its deferred tax assets from 1,004 million yen to 455 million yen after discussions with its audit firm for a more conservative estimate.

The company's financial results for the fiscal year ended August 31, 2025, show net sales of 29,968 million yen, an increase of 5.1% year-on-year, and a profit attributable to owners of parent of 4,643 million yen, a decrease of 26.1%. Mani Inc. also reported a voluntary product recall of "MANI DIA-BURS" in China, impacting operating income by (1,192) million yen, but expects to regain approval and resume sales by the second quarter of the fiscal year ending August 2026.

Looking ahead, Mani Inc. forecasts net sales of 32,800 million yen and profit attributable to owners of parent of 6,450 million yen for the fiscal year ending August 31, 2026, representing a 9.4% and 38.9% year-on-year increase respectively. Strategic initiatives include the expansion of its "JIZAI" series, a partnership with MicroSurgical Technology, and the establishment of "MANI ASIA SDN. BHD." as its Asia regional headquarters. The company also plans to increase its annual dividend to 41 yen per share for the next fiscal year.